Literature DB >> 28247164

Clinical significance of altering epithelial-mesenchymal transition in metastatic lymph nodes of gastric cancer.

Keishi Okubo1, Yoshikazu Uenosono2,3, Takaaki Arigami2,3, Shigehiro Yanagita2, Daisuke Matsushita2, Takashi Kijima2, Masahiko Amatatsu2, Yasuto Uchikado2, Yuko Kijima2, Kosei Maemura2, Shoji Natsugoe2,3.   

Abstract

BACKGROUND: The E-cadherin, N-cadherin, and Snail genes are epithelial-mesenchymal transition (EMT)-inducible genes. Previous studies demonstrated that the expression of EMT markers in the primary tumor sites of gastric cancer correlates with tumor progression and prognosis. However, the clinical significance of the expression of these EMT markers in metastatic lymph nodes remains unclear. In the present study, we investigated the expression of these EMT markers in the primary tumor sites and metastatic lymph nodes.
METHODS: Immunohistochemistry was used to investigate the expression of E-cadherin, N-cadherin, and Snail in 89 primary tumors and 511 metastatic lymph nodes obtained from patients with gastric cancer.
RESULTS: The weak expression of E-cadherin in tumors and lymph nodes increased with more lymph node metastasis and in more undifferentiated tumors. The strong expression of N-cadherin in lymph nodes correlated with more lymph nodes metastasis, an advanced stage, and poor prognosis. The weak expression of Snail in tumors correlated with lymphatic invasion. The strong expression of Snail in lymph nodes correlated with more lymph node metastasis and an advanced stage. The strong expression of Snail in tumors and its weak expression in lymph nodes correlated with more lymph node metastasis, an advanced stage, and poor prognosis.
CONCLUSIONS: The expression of N-cadherin in metastatic lymph nodes is useful for predicting the prognosis of patients with gastric cancer. The Snail switch-namely, the positive-to-negative conversion of the Snail status-between primary tumors and lymph node metastasis may be important for confirming EMT and mesenchymal-epithelial transition.

Entities:  

Keywords:  Epithelial–mesenchymal transition; Gastric cancer; Metastatic lymph nodes; Snail switch

Mesh:

Substances:

Year:  2017        PMID: 28247164     DOI: 10.1007/s10120-017-0705-x

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  36 in total

Review 1.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.

Authors:  Jing Yang; Robert A Weinberg
Journal:  Dev Cell       Date:  2008-06       Impact factor: 12.270

2.  Snail plays a key role in E-cadherin-preserved esophageal squamous cell carcinoma.

Authors:  Shoji Natsugoe; Yasuto Uchikado; Hiroshi Okumura; Masataka Matsumoto; Tetsuro Setoyama; Kiyokazu Tamotsu; Yoshiaki Kita; Akihiko Sakamoto; Testuhiro Owaki; Sumiya Ishigami; Takashi Aikou
Journal:  Oncol Rep       Date:  2007-03       Impact factor: 3.906

Review 3.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 4.  Epithelial-mesenchymal transition: a hallmark in metastasis formation linking circulating tumor cells and cancer stem cells.

Authors:  Magdalena Książkiewicz; Aleksandra Markiewicz; Anna J Zaczek
Journal:  Pathobiology       Date:  2012-04-04       Impact factor: 4.342

Review 5.  Epithelial-mesenchymal transitions: twist in development and metastasis.

Authors:  Yibin Kang; Joan Massagué
Journal:  Cell       Date:  2004-08-06       Impact factor: 41.582

6.  Prognostic value of E-cadherin expression in 413 gastric carcinomas.

Authors:  H E Gabbert; W Mueller; A Schneiders; S Meier; R Moll; W Birchmeier; G Hommel
Journal:  Int J Cancer       Date:  1996-06-21       Impact factor: 7.396

Review 7.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

8.  Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer.

Authors:  Aleksandra Markiewicz; Tomasz Ahrends; Marzena Wełnicka-Jaśkiewicz; Barbara Seroczyńska; Jarosław Skokowski; Janusz Jaśkiewicz; Jolanta Szade; Wojciech Biernat; Anna J Zaczek
Journal:  J Transl Med       Date:  2012-11-19       Impact factor: 5.531

9.  Overexpression of Snail is associated with lymph node metastasis and poor prognosis in patients with gastric cancer.

Authors:  Na Ri Shin; Eun Hui Jeong; Chang In Choi; Hyun Jung Moon; Chae Hwa Kwon; In Sun Chu; Gwang Ha Kim; Tae Yong Jeon; Dae Hwan Kim; Jae Hyuk Lee; Do Youn Park
Journal:  BMC Cancer       Date:  2012-11-14       Impact factor: 4.430

10.  The clinical significance of snail protein expression in gastric cancer: a meta-analysis.

Authors:  Xiaoya Chen; Jinjun Li; Ling Hu; William Yang; Lili Lu; Hongyan Jin; Zexiong Wei; Jack Y Yang; Hamid R Arabnia; Jun S Liu; Mary Qu Yang; Youping Deng
Journal:  Hum Genomics       Date:  2016-07-25       Impact factor: 4.639

View more
  12 in total

Review 1.  Clinical impact of molecular classifications in gastric cancer.

Authors:  Daniele Marrelli; Karol Polom; Alessandro Neri; Franco Roviello
Journal:  Updates Surg       Date:  2018-05-23

Review 2.  Molecular mechanisms underlying the antimetastatic activity of bufalin.

Authors:  Jie Wang; Yue Xia; Qingshong Zuo; Teng Chen
Journal:  Mol Clin Oncol       Date:  2018-03-21

3.  KSR1- and ERK-dependent translational regulation of the epithelial-to-mesenchymal transition.

Authors:  Chaitra Rao; Danielle E Frodyma; Siddesh Southekal; Robert A Svoboda; Adrian R Black; Chittibabu Guda; Tomohiro Mizutani; Hans Clevers; Keith R Johnson; Kurt W Fisher; Robert E Lewis
Journal:  Elife       Date:  2021-05-10       Impact factor: 8.140

Review 4.  Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer.

Authors:  Antoine Legras; Nicolas Pécuchet; Sandrine Imbeaud; Karine Pallier; Audrey Didelot; Hélène Roussel; Laure Gibault; Elizabeth Fabre; Françoise Le Pimpec-Barthes; Pierre Laurent-Puig; Hélène Blons
Journal:  Cancers (Basel)       Date:  2017-08-03       Impact factor: 6.639

Review 5.  EMT: Present and future in clinical oncology.

Authors:  Patricia G Santamaria; Gema Moreno-Bueno; Francisco Portillo; Amparo Cano
Journal:  Mol Oncol       Date:  2017-06-27       Impact factor: 6.603

6.  Activation of the LINC00242/miR-141/FOXC1 axis underpins the development of gastric cancer.

Authors:  Xiongdong Zhong; Xianchang Yu; Xiaoyan Wen; Lei Chen; Ni Gu
Journal:  Cancer Cell Int       Date:  2020-06-24       Impact factor: 5.722

7.  Lymph node metastasis in lung squamous cell carcinoma and identification of metastasis-related genes based on the Cancer Genome Atlas.

Authors:  Ming Dong; Hao Gong; Tong Li; Xin Li; Jinghao Liu; Hongbing Zhang; Minghui Liu; Gang Chen; Hongyu Liu; Jun Chen
Journal:  Cancer Med       Date:  2019-09-03       Impact factor: 4.452

Review 8.  Metabolic reprogramming results in abnormal glycolysis in gastric cancer: a review.

Authors:  Yuanda Liu; Ze Zhang; Junyang Wang; Chao Chen; Xiaohuan Tang; Jiaming Zhu; Jingjing Liu
Journal:  Onco Targets Ther       Date:  2019-02-13       Impact factor: 4.147

9.  Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway.

Authors:  Sutthiwan Janthamala; Apinya Jusakul; Sarinya Kongpetch; Phongsaran Kimawaha; Poramate Klanrit; Watcharin Loilome; Nisana Namwat; Anchalee Techasen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-07-20       Impact factor: 3.000

Review 10.  N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer.

Authors:  Krzysztof Marek Mrozik; Orest William Blaschuk; Chee Man Cheong; Andrew Christopher William Zannettino; Kate Vandyke
Journal:  BMC Cancer       Date:  2018-10-01       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.